NEW ORLEANS – The landscape of global reconstructive surgery entered a new chapter on October 12, 2025, as Babak J. Mehrara, MD, officially assumed the presidency of The Plastic Surgery Foundation (The PSF). The announcement, made during Plastic Surgery The Meeting—the American Society of Plastic Surgeons’ (ASPS) premier annual scientific conference—marks a significant shift in the strategic direction of one of the world’s most influential organizations dedicated to surgical research and global health equity.
Dr. Mehrara, a preeminent authority in oncologic reconstruction and lymphatic biology, succeeds his predecessors with a mandate to bridge the gap between bench-side scientific discovery and clinical patient care. His term, which will conclude on October 18, 2026, is expected to focus on the institutionalization of innovation, the cultivation of early-career investigators, and the expansion of humanitarian surgical outreach.
Main Facts: A Profile of Clinical and Academic Excellence
The appointment of Dr. Mehrara is widely viewed by peers as a logical progression for a surgeon-scientist whose career has been defined by the pursuit of complex, high-impact clinical solutions. Currently serving as the Chief of the Plastic and Reconstructive Surgery Service at Memorial Sloan Kettering Cancer Center (MSK), Dr. Mehrara brings a rare duality to the presidency: the steady hand of a lead clinician and the inquisitive, rigorous mind of a laboratory principal investigator.
At MSK, he holds the prestigious Peter G. Cordeiro Endowed Chair in the Department of Surgery, a position that underscores his commitment to surgical excellence. His work, however, extends far beyond the operating theater. As the director of a National Institutes of Health (NIH)-funded Lymphatic Biology Laboratory, Dr. Mehrara has pioneered investigations into the pathophysiology of lymphatic diseases, specifically cancer-related lymphedema. With over 400 peer-reviewed publications to his name, he has been instrumental in shifting the paradigm of how the medical community approaches post-oncological reconstructive care.
The Plastic Surgery Foundation, the philanthropic and research arm of the ASPS, serves as the engine room for the specialty’s academic advancement. By appointing Dr. Mehrara, the Foundation signals an intent to prioritize research that is not only scientifically robust but also highly translatable to the bedside, ensuring that patients recovering from complex cancer surgeries receive the most advanced care possible.
Chronology: The Road to the Presidency
The transition of leadership at The PSF is a meticulously planned process, reflecting the organization’s commitment to stable, long-term governance.
- Pre-2025: Dr. Mehrara’s reputation for surgical innovation grew through his leadership at MSK and his joint academic appointment at Weill Cornell Medical College, where he serves as Professor of Surgery. His work on lymphatic function garnered international attention, positioning him as a thought leader within the ASPS and The PSF committees.
- Early 2025: Following a period of strategic review, the Board of Directors of The PSF nominated Dr. Mehrara for the presidential term, citing his unique ability to synthesize scientific data with humanitarian outreach goals.
- October 12, 2025: At the annual Plastic Surgery The Meeting in New Orleans, the official handover took place. Dr. Mehrara accepted the mantle of leadership, marking the start of his 12-month tenure.
- October 2025 – October 2026: This period represents the operational phase of his presidency, during which Dr. Mehrara will oversee the funding cycles for research grants, the expansion of the Foundation’s global health partnerships, and the strategic planning for the next decade of plastic surgery education.
- October 18, 2026: Dr. Mehrara is scheduled to conclude his presidential term, passing the leadership to his successor while transitioning into a senior advisory role within the Foundation’s governance structure.
Supporting Data: The Impact of Surgical Innovation
The significance of Dr. Mehrara’s appointment can be measured by the data-driven nature of his contributions to medicine. His research into lymphatic biology addresses a critical, often neglected, side effect of cancer treatment.
The Burden of Lymphedema
Cancer-related lymphedema affects millions of patients worldwide, causing chronic pain, immobility, and a significant decrease in quality of life. Dr. Mehrara’s NIH-funded laboratory has provided the foundational data necessary to understand the molecular mechanisms behind this condition. By identifying the triggers of lymphatic damage, his team has developed diagnostic tools and surgical interventions that have revolutionized recovery protocols.
The Power of Publication
With a bibliography exceeding 400 peer-reviewed entries, Dr. Mehrara’s impact on medical literature is profound. His publications are frequently cited in high-impact journals, influencing clinical practice guidelines globally. This academic rigor is exactly what the Board of The PSF sought to leverage. Under his leadership, the Foundation is expected to increase its funding for "seed" research—grants that allow young investigators to collect preliminary data for larger NIH-scale studies.
Official Responses and Strategic Vision
In his inaugural address to the membership, Dr. Mehrara emphasized that his presidency is not about individual accomplishment, but about fostering an ecosystem of discovery.
"It’s an honor to lead The PSF, and I look forward to building on its legacy of excellence in plastic surgery research and innovation," Dr. Mehrara stated. "I am deeply committed to the advancement of scientific discovery and supporting the work of residents, early-career researchers, and emerging innovators. Throughout my presidency, I will champion new ways to strengthen and expand The Foundation’s mission of research and education."
This response reflects a core pillar of his philosophy: that the future of plastic surgery rests on the shoulders of the next generation. By providing mentorship and financial backing to early-career professionals, Dr. Mehrara aims to create a pipeline of talent that will sustain the Foundation’s mission for decades.
A Focus on Global Partnerships
Beyond the laboratory, the Foundation plays a vital role in international outreach. Dr. Mehrara has signaled that he intends to strengthen partnerships with global medical institutions to ensure that the advancements made in high-resource settings are adapted and shared with surgeons working in low-resource environments. This is a critical component of the Foundation’s mandate to make safe, effective, and affordable reconstructive surgery accessible to all.
Implications: The Future of Plastic Surgery
The appointment of a surgeon-scientist of Dr. Mehrara’s caliber suggests a pivot in the priorities of The Plastic Surgery Foundation. As healthcare systems globally face the pressures of aging populations, increased cancer incidence, and rising costs, the role of reconstructive surgery is becoming more essential than ever.
1. Integrating Technology and Biology
Under Dr. Mehrara’s guidance, the Foundation is expected to invest heavily in the integration of biological research with surgical technology. This includes advancements in microsurgery, tissue engineering, and lymphatic reconstruction—areas where Dr. Mehrara has already demonstrated significant expertise.
2. Democratizing Access
A key implication of his term is the focus on the scalability of surgical techniques. By championing "effective and affordable" care, the Foundation is positioning itself to be a leader in global health diplomacy. The goal is to move beyond short-term medical missions and toward sustainable, capacity-building programs that train local surgeons in modern reconstructive techniques.
3. Strengthening the Foundation’s Financial Health
The PSF relies on the support of donors, industry partners, and the ASPS membership. Dr. Mehrara’s reputation in the scientific community is expected to serve as a catalyst for increased philanthropic engagement. By demonstrating a high return on investment—measured in clinical outcomes and scientific breakthroughs—the Foundation aims to attract a broader base of funding.
4. Setting the Research Agenda
The research agenda set during the next 12 months will dictate the trajectory of the specialty for years to come. By focusing on oncologic reconstruction, Dr. Mehrara is aligning the Foundation with the most pressing clinical needs of the current era. As cancer survival rates improve, the demand for reconstructive surgery that restores function and quality of life is at an all-time high. Dr. Mehrara’s leadership ensures that the plastic surgery community is prepared to meet this demand with evidence-based solutions.
Conclusion
As Dr. Babak J. Mehrara begins his tenure, the plastic surgery community looks toward a year characterized by rigorous inquiry and a renewed commitment to the patient experience. His journey from the operating rooms of Memorial Sloan Kettering to the helm of The Plastic Surgery Foundation is a testament to the power of combining surgical skill with scientific dedication.
As the world watches, the impact of his work will likely be felt not only in the high-tech laboratories of the United States but in the clinics and hospitals around the globe where his research is translated into restored form, function, and dignity for cancer survivors. The PSF, under his leadership, is poised to remain the heartbeat of innovation in a specialty that continues to redefine the boundaries of human recovery.
About the Author
